ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Good bacteria for baldness? new trial tests probiotic lotion against hair loss
Disease control Recruiting nowThis study tests if a lotion made with Lactobacillus reuteri, a friendly bacteria, can safely help regrow hair in people with pattern baldness. About 388 adults will use the probiotic lotion, a placebo, or standard minoxidil for 12 months. The goal is to see if balancing scalp ba…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2 • Sponsor: Shenzhen People's Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Hair loss breakthrough? new injection trial aims to regrow hair
Disease control Recruiting nowThis study tests a new drug called OLX72021 in healthy men with mild to moderate male pattern baldness. The goal is to see if it is safe and can increase hair count. Participants receive multiple injections into the scalp and are monitored for side effects and hair growth over 24…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE1, PHASE2 • Sponsor: Olix Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New peptide serum takes on hair loss in head-to-head trial
Disease control Recruiting nowThis study compares a new peptide-based hair serum to the standard treatment minoxidil for people with pattern baldness. About 80 adults with mild to moderate hair loss will use one of the two treatments for 24 weeks. Researchers will measure changes in hair density and thickness…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: Institute of Dermatology, Thailand • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Botox and blood plasma: new combo for baldness?
Disease control Recruiting nowThis study tests whether combining platelet-rich plasma (PRP) with Botox injections works better than PRP alone for treating androgenetic alopecia (common baldness). About 76 adults aged 18 to 60 with mild to moderate hair loss will receive monthly scalp injections for three mont…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
New pill could help women regrow hair – major trial underway
Disease control Recruiting nowThis study tests an experimental oral drug called VDPHL01 for women with genetic hair loss (androgenetic alopecia). About 552 women aged 18-65 with mild to moderate hair loss will receive either the drug or a placebo for 13 months. The main goal is to see if the drug increases ha…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC
-
New hair loss drug enters human trials – could it be the answer for baldness?
Symptom relief Recruiting nowThis early-stage study tests a new medication called ABS-201 to see if it is safe and tolerable for improving hair growth. It starts with healthy volunteers and then includes people with a common type of hair loss (androgenetic alopecia). Participants receive either ABS-201 or a …
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE1, PHASE2 • Sponsor: Absci Pty Ltd. • Aim: Symptom relief
Last updated Jun 15, 2026 19:06 UTC